DOI: 10.1200/jco-26-01958 ISSN: 0732-183X
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3
Paul Wheatley Price, Nofisat Ismaila, Antonio Calles Blanco, Jeremy Cetnar, Terri Conneran, Parth A. Desai, Greg Durm, Hidehito Horinouchi, Humera Khurshid, Swati Kulkarni, Kristen Ashley Marrone, Kirstin Perdrizet, Lyudmila Bazhenova
This guideline has been updated.
This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the
online dynamic version
for the latest updates.
Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the
ASCO Guidelines Methodology Manual
.
ASCO Living Guidelines follow the
ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines
.
Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the
ASCO Publications website
.